21 C.F.R. § 522.2065

Current through October 31, 2024
Section 522.2065 - Rabacfosadine
(a)Specifications. Each vial of powder contains 16.4 milligrams (mg) rabacfosadine. Each milliliter of constituted solution contains 8.2 mg rabacfosadine.
(b)Sponsor. See No. 058198 in § 510.600(c) of this chapter.
(c)Conditions of use in dogs -
(1)Amount. Administer rabacfosadine at 1 mg/kilogram body weight as a 30-minute intravenous infusion, once every 3 weeks, for up to 5 doses.
(2)Indications for use. For the treatment of lymphoma in dogs.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

21 C.F.R. §522.2065

87 FR 10969 , Feb. 28, 2022
87 FR 10969 , 2/28/2022